查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930054

全球生命科学分析市场：市场规模、占有率、成长率、产业分析、按类型、应用和地区划分的考量因素以及未来预测（2025-2034）

Life Science Analytics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 149 Pages | 商品交期: 请询问到货日

价格

生命科学分析市场的成长驱动因素

预计2025年，全球生命科学分析市场规模将达到137.8亿美元，2026年将成长至150亿美元，最终到2034年将达到357亿美元，在预测期内维持11.45%的强劲复合年增长率。北美将在2025年以43.3%的市占率引领市场，这主要得益于高额的研发投入、强大的医疗保健IT基础设施以及先进分析技术在临床试验中的广泛应用。

生命科学分析涵盖了製药公司、生物技术公司和合约研究组织（CRO）用于优化药物发现、临床试验、个人化医疗和营运效率的软体、解决方案和分析应用程式。市场主要参与者包括 Oracle 公司、SAS 研究所、埃森哲、Viva Systems 和 IBM。人工智慧、机器学习和云端分析平台的日益普及正在推动市场成长。

例如，Oracle 于 2024 年 10 月发布了 Oracle Analytics Intelligence，这是一款面向生命科学领域的人工智慧解决方案，能够从各种资料来源中快速提取洞察，从而加速开发更精准的治疗方法。

市场动态

市场驱动因素

临床试验中分析工具的日益普及正在改善患者招募、即时监测和个人化治疗方案的开发。利用 SAS 生命科学分析框架和 ClinACT 等分析平台加速临床前试验（评估疗效、毒性和安全性）正在降低药物研发的成本和时间。策略伙伴关係，例如 Clarivate 与 VeriSIM Life 的合作（2023 年 12 月）以及 IQVIA 的 "One Home for Sites" 服务的推出（2024 年 6 月），正在进一步促进数据分析和临床营运效率的提升。

此外，医院对医疗数据管理平台的日益普及以及医疗支出的成长也推动了市场成长。例如，预计到 2028 年，美国全国医疗支出将达到 6.3 兆美元，这将推动对用于监管合规、成本效益评估和营运效率的分析平台的需求。

市场限制因子

高昂的实施成本（从 10 万美元到 125 万美元不等）以及对资料外洩的担忧限制了其普及。虽然基于云端的分析效率很高，但也存在网路安全风险。例如，预计到 2022 年，大规模资料外洩的平均成本将增加至 2.41 亿美元，凸显了资料安全的重要性。

机会

在新兴市场，医疗基础设施的建设和数位化技术的进步正在创造丰厚的机会。各公司正在投资分析解决方案，以拓展到印度、中国和非洲等服务不足的地区。例如，PBR Life Sciences（2024 年 12 月）获得了 100 万美元的融资，用于在非洲扩展其医疗分析工具。

挑战

资料整合复杂性、熟练专业人员短缺以及严格的监管合规要求仍然是生命科学分析工具在全球营运中部署的挑战。

市场区隔

按类型划分：到 2026 年，服务将占领先地位，市场占有率达 61.7%，这主要得益于临床试验、药物研发和监管合规领域的广泛应用。软体解决方案预计将稳定成长，这得益于 Axtria 的人工智慧驱动解决方案等创新技术（2024 年 3 月发布）。

以交付方式划分：到 2026 年，随选/云端服务将占榜首，市占率达 53.08%。在製药公司和合约研究组织 (CRO) 的推动下，这些服务能够提高营运效率并加速临床试验分析。

按应用划分：到 2026 年，临床研究分析将占 53.44% 的市场占有率，这主要得益于药物研发、临床试验和研究领域的应用。对精准医疗和营运效率日益增长的需求也推动了商业分析、个人化医疗和供应链分析的成长。

按最终用户划分：製药和生物技术公司将在2026年占40.09%的市场占有率，凭藉持续的研发投入，继续保持领先地位。合约研究组织（CRO）和医疗器材公司正经历显着成长，尤其是在个人化医疗和分析解决方案的扩展方面。

区域分析

北美市场在2025年以59.7亿美元的规模领先，预计到2026年将达到59.5亿美元，这主要得益于其完善的研发中心和分析工具的广泛应用。欧洲紧追在后，在医疗保健分析领域投入大量资金。英国市场预计2026年将达到8.6亿美元，德国紧追在后，达到10.1亿美元。亚太地区预计将呈现最高的成长率，这得益于新兴的医疗保健基础设施、临床试验以及在印度、中国和日本的投资。拉丁美洲市场呈现稳定成长，而中东和非洲地区由于应用有限但投资机会不断增加，成长速度放缓。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 生命科学分析领域的技术进步
  • 关键产业趋势：併购、业务合作
  • 新产品发布
  • 新冠疫情对市场的影响

第五章 全球生命科学分析市场分析：洞察与预测 （2021-2034）

  • 市场分析、洞察与预测：依类型划分
    • 软体与解决方案
    • 服务
  • 市场分析、洞察与预测：以交付方式划分
    • 本地部署
    • 按需部署
  • 市场分析、洞察与预测：依应用划分
    • 商业分析
    • 个人化治疗
    • 临床研究分析
    • 供应链分析
  • 市场分析、洞察与预测：依最终用户划分
    • 医疗器材製造商
    • 製药与生技公司
    • 合约研究组织 (CRO)
    • 其他
  • 市场分析、洞察与预测：按地区划分
    • 北美美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美生命科学分析市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲生命科学分析市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章 亚太生命科学分析市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 韩国
    • 亚太其他地区

第九章：拉丁美洲生命科学分析市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第十章：中东与非洲生命科学分析市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会
    • 南非
    • 中东其他地区非洲

第十一章 竞争分析

  • 全球市占率分析（2025 年）
  • 公司简介
  • SAS Institute Inc.
  • 埃森哲
  • Veeva Systems
  • IBM
  • Oracle
  • Analytics8
  • IQVIA Inc.
  • 其他主要参与者
Product Code: FBI108603

Growth Factors of life science analytics Market

The global life science analytics market was valued at USD 13.78 billion in 2025 and is projected to grow to USD 15 billion in 2026, ultimately reaching USD 35.7 billion by 2034, exhibiting a robust CAGR of 11.45% during the forecast period. North America led the market in 2025 with a 43.3% share, driven by high R&D investment, strong healthcare IT infrastructure, and widespread adoption of advanced analytics in clinical trials.

Life science analytics encompasses software, solutions, and analytical applications that enable pharmaceutical, biotechnology, and contract research organizations (CROs) to optimize drug discovery, clinical trials, personalized therapies, and operational efficiency. Major players in the market include Oracle Corporation, SAS Institute Inc., Accenture, Veeva Systems Inc., and IBM, among others. The growing adoption of AI, machine learning, and cloud-based analytics platforms is fueling market expansion.

For example, in October 2024, Oracle launched AI-powered Oracle Analytics Intelligence for life sciences, enabling faster insights from diverse data sources, thus accelerating the development of therapies with greater precision.

Market Dynamics

Growth Factors:

The increasing use of analytical tools in clinical trials is improving patient recruitment, real-time monitoring, and development of personalized therapies. Preclinical studies for efficacy, toxicity, and safety assessment are being accelerated using analytical platforms like SAS Life Science Analytics Framework and ClinACT, reducing both cost and time for drug development. Strategic partnerships such as Clarivate and VeriSIM Life (December 2023) and IQVIA's 'One Home for Sites' (June 2024) are further enhancing the efficiency of data analysis and clinical operations.

Additionally, the growing adoption of healthcare data management platforms in hospitals, coupled with rising healthcare expenditures, supports market growth. For instance, the U.S. National Healthcare Expenditure is projected to reach USD 6.3 trillion by 2028, driving demand for analytics platforms for regulatory compliance, cost-effectiveness assessment, and operational efficiency.

Restraints:

High implementation costs, which may range from USD 100,000 to USD 1.25 million, and concerns over data breaches are restraining adoption. Cloud-based analytics, while efficient, also pose cybersecurity risks. For example, the average cost of a mega data breach increased to USD 241 million in 2022, highlighting the importance of data security.

Opportunities:

Emerging markets present lucrative opportunities due to rising healthcare infrastructure and digitalization. Companies are investing in analytics solutions to penetrate untapped regions such as India, China, and Africa. For instance, PBR Life Sciences (December 2024) secured USD 1 million funding to expand healthcare analytics tools in Africa.

Challenges:

Data integration complexities, shortage of skilled professionals, and stringent regulatory compliance requirements remain challenges in deploying life science analytics tools across global operations.

Market Segmentation

By Type: Services dominated with a 61.7% share in 2026, driven by widespread adoption in clinical trials, drug development, and regulatory compliance. Software & solutions are expected to grow steadily, supported by innovations such as Axtria's AI-driven solutions (March 2024).

By Delivery: On-demand/cloud services led with 53.08% share in 2026, fueled by adoption in pharmaceutical companies and CROs, enabling streamlined operations and faster clinical trial analysis.

By Application: Clinical research analytics held a 53.44% share in 2026, driven by adoption in drug development, clinical trials, and research. Commercial analytics, personalized therapy, and supply chain analytics segments are also experiencing growth due to rising demand for precision medicine and operational efficiency.

By End-Users: Pharma & biotech companies dominated with a 40.09% share in 2026, owing to continuous investment in R&D. CROs and medical device companies are witnessing substantial growth, particularly with increasing adoption of personalized medicine and analytics solutions.

Regional Insights

North America led with USD 5.97 billion in 2025, projected to reach USD 5.95 billion in 2026, driven by established R&D centers and adoption of analytical tools. Europe follows with strong funding for healthcare analytics; the UK market is projected at USD 0.86 billion in 2026, Germany at USD 1.01 billion. Asia Pacific is expected to register the highest growth, supported by emerging healthcare infrastructure, clinical trials, and investments in India, China, and Japan. Latin America shows steady growth, while the Middle East & Africa grow slower due to limited adoption but emerging investment opportunities.

Competitive Landscape

Key players include Oracle, Accenture, SAS Institute, IQVIA, Veeva Systems, and IBM, focusing on collaborations, acquisitions, and technological innovations to expand market share. Notable developments include Accenture's acquisition of consus.health (August 2024) and Oracle's CancerMPact service (September 2024) for global cancer treatment trend analysis.

Conclusion

The global life science analytics market is on a strong growth trajectory, expanding from USD 13.78 billion in 2025 to USD 15 billion in 2026 and expected to reach USD 35.7 billion by 2034 at a CAGR of 11.45%. The market is driven by the growing adoption of AI, cloud services, and advanced analytics in pharma, biotech, and CROs for drug development, clinical research, and personalized medicine. North America continues to lead, while Asia Pacific offers the fastest growth potential. Despite challenges such as high implementation costs, data integration issues, and regulatory compliance, technological innovations, strategic partnerships, and the rising demand for cloud-based services and personalized therapies are poised to sustain market expansion and transform the life sciences industry globally.

Segmentation By Type

  • Software & Solutions
  • Services

By Delivery

  • On-premise
  • On-demand

By Application

  • Commercial Analytics
  • Personalized Therapy
  • Clinical Research Analytics
  • Supply Chain Analytics

By End User

  • Medical Device Companies
  • Pharma & Biotech Companies
  • Contract Research Organizations
  • Others

By Region

  • North America (By Type, By Delivery, By Application, By End Users, By Country)
    • U.S.
    • Canada
  • Europe (By Type, By Delivery, By Application, By End Users, By Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, By Delivery, By Application, By End Users, By Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of the Asia Pacific
  • Latin America (By Type, By Delivery, By Application, By End Users, By Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, By Delivery, By Application, By End Users, By Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements in Life Science Analytics
  • 4.2. Key Industry Developments- Mergers, Acquisitions & Partnerships
  • 4.3. New Product Launches
  • 4.4. Impact of COVID-19 on the Market

5. Global Life Science Analytics Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Software & Solutions
    • 5.1.2. Services
  • 5.2. Market Analysis, Insights and Forecast - By Delivery
    • 5.2.1. On-premise
    • 5.2.2. On-demand
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Commercial Analytics
    • 5.3.2. Personalized Therapy
    • 5.3.3. Clinical Research Analytics
    • 5.3.4. Supply Chain Analytics
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Medical Device Companies
    • 5.4.2. Pharma & Biotech Companies
    • 5.4.3. Contract Research Organizations
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East and Africa

6. North America Life Science Analytics Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Software & Solutions
    • 6.1.2. Services
  • 6.2. Market Analysis, Insights and Forecast - By Delivery
    • 6.2.1. On-premise
    • 6.2.2. On-demand
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Commercial Analytics
    • 6.3.2. Personalized Therapy
    • 6.3.3. Clinical Research Analytics
    • 6.3.4. Supply Chain Analytics
  • 6.4. Market Analysis, Insights and Forecast - By End User
    • 6.4.1. Medical Device Companies
    • 6.4.2. Pharma & Biotech Companies
    • 6.4.3. Contract Research Organizations
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Life Science Analytics Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Software & Solutions
    • 7.1.2. Services
  • 7.2. Market Analysis, Insights and Forecast - By Delivery
    • 7.2.1. On-premise
    • 7.2.2. On-demand
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Commercial Analytics
    • 7.3.2. Personalized Therapy
    • 7.3.3. Clinical Research Analytics
    • 7.3.4. Supply Chain Analytics
  • 7.4. Market Analysis, Insights and Forecast - By End User
    • 7.4.1. Medical Device Companies
    • 7.4.2. Pharma & Biotech Companies
    • 7.4.3. Contract Research Organizations
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Life Science Analytics Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Software & Solutions
    • 8.1.2. Services
  • 8.2. Market Analysis, Insights and Forecast - By Delivery
    • 8.2.1. On-premise
    • 8.2.2. On-demand
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Commercial Analytics
    • 8.3.2. Personalized Therapy
    • 8.3.3. Clinical Research Analytics
    • 8.3.4. Supply Chain Analytics
  • 8.4. Market Analysis, Insights and Forecast - By End User
    • 8.4.1. Medical Device Companies
    • 8.4.2. Pharma & Biotech Companies
    • 8.4.3. Contract Research Organizations
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. South Korea
    • 8.5.6. Rest of Asia Pacific

9. Latin America Life Science Analytics Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Software & Solutions
    • 9.1.2. Services
  • 9.2. Market Analysis, Insights and Forecast - By Delivery
    • 9.2.1. On-premise
    • 9.2.2. On-demand
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Commercial Analytics
    • 9.3.2. Personalized Therapy
    • 9.3.3. Clinical Research Analytics
    • 9.3.4. Supply Chain Analytics
  • 9.4. Market Analysis, Insights and Forecast - By End User
    • 9.4.1. Medical Device Companies
    • 9.4.2. Pharma & Biotech Companies
    • 9.4.3. Contract Research Organizations
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Life Science Analytics Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Software & Solutions
    • 10.1.2. Services
  • 10.2. Market Analysis, Insights and Forecast - By Delivery
    • 10.2.1. On-premise
    • 10.2.2. On-demand
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Commercial Analytics
    • 10.3.2. Personalized Therapy
    • 10.3.3. Clinical Research Analytics
    • 10.3.4. Supply Chain Analytics
  • 10.4. Market Analysis, Insights and Forecast - By End User
    • 10.4.1. Medical Device Companies
    • 10.4.2. Pharma & Biotech Companies
    • 10.4.3. Contract Research Organizations
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. SAS Institute Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. SWOT Analysis
      • 11.2.1.3. Recent Developments
      • 11.2.1.4. Strategies
      • 11.2.1.5. financials (Based on Availability)
    • 11.2.2. Accenture
      • 11.2.2.1. Overview
      • 11.2.2.2. SWOT Analysis
      • 11.2.2.3. Recent Developments
      • 11.2.2.4. Strategies
      • 11.2.2.5. financials (Based on Availability)
    • 11.2.3. Veeva Systems
      • 11.2.3.1. Overview
      • 11.2.3.2. SWOT Analysis
      • 11.2.3.3. Recent Developments
      • 11.2.3.4. Strategies
      • 11.2.3.5. financials (Based on Availability)
    • 11.2.4. IBM
      • 11.2.4.1. Overview
      • 11.2.4.2. SWOT Analysis
      • 11.2.4.3. Recent Developments
      • 11.2.4.4. Strategies
      • 11.2.4.5. financials (Based on Availability)
    • 11.2.5. Oracle
      • 11.2.5.1. Overview
      • 11.2.5.2. SWOT Analysis
      • 11.2.5.3. Recent Developments
      • 11.2.5.4. Strategies
      • 11.2.5.5. financials (Based on Availability)
    • 11.2.6. Analytics8
      • 11.2.6.1. Overview
      • 11.2.6.2. SWOT Analysis
      • 11.2.6.3. Recent Developments
      • 11.2.6.4. Strategies
      • 11.2.6.5. financials (Based on Availability)
    • 11.2.7. IQVIA Inc
      • 11.2.7.1. Overview
      • 11.2.7.2. SWOT Analysis
      • 11.2.7.3. Recent Developments
      • 11.2.7.4. Strategies
      • 11.2.7.5. financials (Based on Availability)
    • 11.2.8. Other Prominent Players
      • 11.2.8.1. Overview
      • 11.2.8.2. SWOT Analysis
      • 11.2.8.3. Recent Developments
      • 11.2.8.4. Strategies
      • 11.2.8.5. financials (Based on Availability)

List of Tables

  • Table 01: Global Life Science Analytics Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 02: Global Life Science Analytics Market Revenue (USD billion) Forecast, By Delivery, 2021-2034
  • Table 03: Global Life Science Analytics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 04: Global Life Science Analytics Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 05: Global Life Science Analytics Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 06: North America Life Science Analytics Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 07: North America Life Science Analytics Market Revenue (USD billion) Forecast, By Delivery, 2021-2034
  • Table 08: North America Life Science Analytics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 09: North America Life Science Analytics Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 10: North America Life Science Analytics Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Life Science Analytics Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 12: Europe Life Science Analytics Market Revenue (USD billion) Forecast, By Delivery, 2021-2034
  • Table 13: Europe Life Science Analytics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 14: Europe Life Science Analytics Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 15: Europe Life Science Analytics Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034
  • Table 16: Asia Pacific Life Science Analytics Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 17: Asia Pacific Life Science Analytics Market Revenue (USD billion) Forecast, By Delivery, 2021-2034
  • Table 18: Asia Pacific Life Science Analytics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 19: Asia Pacific Life Science Analytics Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 20: Asia Pacific Life Science Analytics Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034
  • Table 21: Latin America Life Science Analytics Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 22: Latin America Life Science Analytics Market Revenue (USD billion) Forecast, By Delivery, 2021-2034
  • Table 23: Latin America Life Science Analytics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 24: Latin America Life Science Analytics Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 25: Latin America Life Science Analytics Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034
  • Table 26: Middle East & Africa Life Science Analytics Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 27: Middle East & Africa Life Science Analytics Market Revenue (USD billion) Forecast, By Delivery, 2021-2034
  • Table 28: Middle East & Africa Life Science Analytics Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 29: Middle East & Africa Life Science Analytics Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 30: Middle East & Africa Life Science Analytics Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034

List of Figures

  • Figure 01: Global Life Science Analytics Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 02: Global Life Science Analytics Market Revenue Share (%), By Type, 2025 & 2034
  • Figure 03: Global Life Science Analytics Market Revenue Share (%), By Delivery, 2025 & 2034
  • Figure 04: Global Life Science Analytics Market Revenue Share (%), By Application, 2025 & 2034
  • Figure 05: Global Life Science Analytics Market Revenue Share (%), By End User, 2025 & 2034
  • Figure 06: Global Life Science Analytics Market Value (USD billion), By Region, 2025 & 2034
  • Figure 07: North America Life Science Analytics Market Value (USD billion), by Type, 2025 & 2034
  • Figure 08: North America Life Science Analytics Market Value Share (%), by Type, 2025
  • Figure 09: North America Life Science Analytics Market Value (USD billion), by Delivery, 2025 & 2034
  • Figure 10: North America Life Science Analytics Market Value Share (%), by Delivery, 2025
  • Figure 11: North America Life Science Analytics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 12: North America Life Science Analytics Market Value Share (%), by Application, 2025
  • Figure 13: North America Life Science Analytics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 14: North America Life Science Analytics Market Value Share (%), by End User, 2025
  • Figure 15: North America Life Science Analytics Market Value (USD billion), by Country, 2025 & 2034
  • Figure 16: North America Life Science Analytics Market Value Share (%), by Country, 2025
  • Figure 17: Europe Life Science Analytics Market Value (USD billion), by Type, 2025 & 2034
  • Figure 18: Europe Life Science Analytics Market Value Share (%), by Type, 2025
  • Figure 19: Europe Life Science Analytics Market Value (USD billion), by Delivery, 2025 & 2034
  • Figure 20: Europe Life Science Analytics Market Value Share (%), by Delivery, 2025
  • Figure 21: Europe Life Science Analytics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 22: Europe Life Science Analytics Market Value Share (%), by Application, 2025
  • Figure 23: Europe Life Science Analytics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 24: Europe Life Science Analytics Market Value Share (%), by End User, 2025
  • Figure 25: Europe Life Science Analytics Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 26: Europe Life Science Analytics Market Value Share (%), by Country/Sub-region, 2025
  • Figure 27: Asia Pacific Life Science Analytics Market Value (USD billion), by Type, 2025 & 2034
  • Figure 28: Asia Pacific Life Science Analytics Market Value Share (%), by Type, 2025
  • Figure 29: Asia Pacific Life Science Analytics Market Value (USD billion), by Delivery, 2025 & 2034
  • Figure 30: Asia Pacific Life Science Analytics Market Value Share (%), by Delivery, 2025
  • Figure 31: Asia Pacific Life Science Analytics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 32: Asia Pacific Life Science Analytics Market Value Share (%), by Application, 2025
  • Figure 33: Asia Pacific Life Science Analytics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 34: Asia Pacific Life Science Analytics Market Value Share (%), by End User, 2025
  • Figure 35: Asia Pacific Life Science Analytics Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Life Science Analytics Market Value Share (%), by Country/Sub-region, 2025
  • Figure 37: Latin America Life Science Analytics Market Value (USD billion), by Type, 2025 & 2034
  • Figure 38: Latin America Life Science Analytics Market Value Share (%), by Type, 2025
  • Figure 39: Latin America Life Science Analytics Market Value (USD billion), by Delivery, 2025 & 2034
  • Figure 40: Latin America Life Science Analytics Market Value Share (%), by Delivery, 2025
  • Figure 41: Latin America Life Science Analytics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 42: Latin America Life Science Analytics Market Value Share (%), by Application, 2025
  • Figure 43: Latin America Life Science Analytics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 44: Latin America Life Science Analytics Market Value Share (%), by End User, 2025
  • Figure 45: Latin America Life Science Analytics Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 46: Latin America Life Science Analytics Market Value Share (%), by Country/Sub-region, 2025
  • Figure 47: Middle East & Africa Life Science Analytics Market Value (USD billion), by Type, 2025 & 2034
  • Figure 48: Middle East & Africa Life Science Analytics Market Value Share (%), by Type, 2025
  • Figure 49: Middle East & Africa Life Science Analytics Market Value (USD billion), by Delivery, 2025 & 2034
  • Figure 50: Middle East & Africa Life Science Analytics Market Value Share (%), by Delivery, 2025
  • Figure 51: Middle East & Africa Life Science Analytics Market Value (USD billion), by Application, 2025 & 2034
  • Figure 52: Middle East & Africa Life Science Analytics Market Value Share (%), by Application, 2025
  • Figure 53: Middle East & Africa Life Science Analytics Market Value (USD billion), by End User, 2025 & 2034
  • Figure 54: Middle East & Africa Life Science Analytics Market Value Share (%), by End User, 2025
  • Figure 55: Middle East & Africa Life Science Analytics Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Life Science Analytics Market Value Share (%), by Country/Sub-region, 2025
  • Figure 57: Global Life Science Analytics Market Share (%), 2025